Aries Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-4,356
Closed -$375K – 233
2024
Q4
$375K Hold
4,356
– – 0.1% 161
2024
Q3
$519K Buy
+4,356
New +$581K 0.14% 130

Other funds holding NVO

Aries Wealth Management's NVO Position: Q1 2025 in Review

Aries Wealth Management sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 4,356 shares — an estimated $375K sold.

Aries Wealth Management first reported a position in NVO in Q3 2024 and held it in 2 quarters. The position peaked at $519K in Q3 2024. 1,533 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Aries Wealth Management reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Aries Wealth Management sold 4,356 Novo Nordisk shares in Q1 2025, an estimated $375K.
  • Aries Wealth Management first reported a position in Novo Nordisk in Q3 2024 and held it in 2 quarters.
  • Aries Wealth Management's Novo Nordisk position peaked at $519K in Q3 2024.
  • 1,533 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Aries Wealth Management's 13F filing for Q1 2025, filed 17 Apr 2025.